Article Details

Luxa Biotechnology LLC Appoints Keith E. Dionne, Ph.D., as Chief Executive Officer

Retrieved on: 2024-10-01 20:07:10

Tags for this article:

Click the tags to see associated articles and topics

Luxa Biotechnology LLC Appoints Keith E. Dionne, Ph.D., as Chief Executive Officer. View article details on hiswai:

Summary

The article discusses Luxa Biotechnology's development of RPESC therapy for dry age-related macular degeneration, a type of regenerative medicine. The key concept and tags highlight the use of stem cells, specifically RPESC, in treating eye diseases like macular degeneration.

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up